We are live on
!
Find out more
GQG Partners Portfolio holdings
AUM
$53.8B
1-Year Est. Return
19.23%
This Fund
S&P 500
This Quarter
Est. Return
-8.52%
1 Year Est. Return
+19.23%
3 Year Est. Return
+225.42%
5 Year Est. Return
+476.53%
10 Year Est. Return
–
AUM
$14.5B
AUM Growth
+$53.5M
(+0.37%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.16%
Top 10 Holdings %
Top 10 Hldgs %
58.06%
Holding
78
New
21
Increased
28
Reduced
5
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$395M |
| 2 |
Mercado Libre
MELI
|
+$358M |
| 3 |
Intuit
INTU
|
+$346M |
| 4 |
NVIDIA
NVDA
|
+$338M |
| 5 |
Coca-Cola
KO
|
+$321M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$671M |
| 2 |
Bank of America
BAC
|
+$509M |
| 3 |
Intercontinental Exchange
ICE
|
+$357M |
| 4 |
Procter & Gamble
PG
|
+$276M |
| 5 |
UnitedHealth
UNH
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.95% |
| 2 | Consumer Discretionary | 19.46% |
| 3 | Financials | 14.98% |
| 4 | Healthcare | 13.82% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
51
Novo Nordisk
NVO
$205B
| $1.71M | 0.01% |
56,714
+42,132
| +289% | +$1.25M |
|
52
Edwards Lifesciences
EW
$51.8B
| $284K | ﹤0.01% |
4,518
| – | – |
|
53
Zoetis
ZTS
$31B
| $249K | ﹤0.01% |
2,118
| – | – |
|
54
Merck
MRK
$369B
| $237K | ﹤0.01% |
3,224
-1,703
| -35% | -$134K |
|
55
Diageo
DEO
$51.2B
| $226K | ﹤0.01% |
+1,777
| New | +$267K |
|
56
Veeva Systems
VEEV
$45.8B
| $219K | ﹤0.01% |
+1,400
| New | +$205K |
|
57
Insulet
PODD
$9.95B
| $205K | ﹤0.01% |
1,240
| – | – |
|
58
Genmab
GMAB
$21B
| $202K | ﹤0.01% |
9,512
| – | – |
|
59
Broadcom
AVGO
$1.77T
| – | – |
-4,292,160
| Closed | -$136M |
|
|
60
Bank of America
BAC
$428B
| – | – |
-14,450,855
| Closed | -$509M |
|
61
Banco Bradesco
BBD
$34.2B
| – | – |
-12,851,171
| Closed | -$86.4M |
|
62
Becton Dickinson
BDX
$51.2B
| – | – |
-1,326
| Closed | -$352K |
|
63
Bio-Rad Laboratories Class A
BIO
$10.4B
| – | – |
-568
| Closed | -$210K |
|
64
Berkshire Hathaway Class B
BRK.B
$1.08T
| – | – |
-1,014,382
| Closed | -$230M |
|
65
Blackstone
BX
$108B
| – | – |
-2,151,718
| Closed | -$120M |
|
|
66
Citigroup
C
$223B
| – | – |
-8,401,450
| Closed | -$671M |
|
67
Delta Air Lines
DAL
$53.4B
| – | – |
-2,062,056
| Closed | -$121M |
|
68
Meta Platforms (Facebook)
META
$1.45T
| – | – |
-768,820
| Closed | -$158M |
|
69
Novartis
NVS
$294B
| – | – |
-4,442
| Closed | -$421K |
|
70
Pfizer
PFE
$160B
| – | – |
-9,538
| Closed | -$355K |
|
|
71
Procter & Gamble
PG
$333B
| – | – |
-2,209,205
| Closed | -$276M |
|
72
Qualcomm
QCOM
$176B
| – | – |
-1,059,325
| Closed | -$93.5M |
|
|
SCHW
73
Charles Schwab
SCHW
$187B
| – | – |
-334,996
| Closed | -$15.9M |
|
74
Stryker
SYK
$124B
| – | – |
-784,064
| Closed | -$165M |
|
75
Target
TGT
$75.4B
| – | – |
-1,132,870
| Closed | -$145M |
|
Similar funds
HF
GQG Partners's Q1 2020 Portfolio in Review
As of Q1 2020, GQG Partners held 78 positions worth $14.5B, up 0.37% from $14.5B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
GQG Partners deployed $1.91B of net new capital in Q1 2020, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was ServiceNow: 6,322,635 shares worth $363M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $357M trimmed.
- GQG Partners's largest Q1 2020 buy was ServiceNow: 6,322,635 shares worth $363M.
- GQG Partners added most to NVIDIA in Q1 2020, an estimated $338M increase.
- GQG Partners's biggest Q1 2020 reduction was Intercontinental Exchange, cutting an estimated $357M.
- GQG Partners fully exited Citigroup in Q1 2020, selling an estimated $671M.
- GQG Partners's ten largest holdings make up 58% of its $14.5B portfolio in Q1 2020.
- GQG Partners opened 21 new positions and closed 20 in Q1 2020.
- GQG Partners's portfolio value rose 0.37% quarter-over-quarter to $14.5B.
Based on GQG Partners's 13F filing for Q1 2020, filed 14 May 2020.